TimeScale Financial’s Pfizer PFE Stock Holding History

TimeScale Financial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$142K	Buy	3,882 +25	+0.6%	+$973	0.03%	124
2023 Q1	$157K	Sell	3,857 -3,062	-44%	-$132K	0.04%	110
2022 Q4	$303K	Hold	6,919	–	–	0.09%	42
2022 Q3	$303K	Buy	6,919 +52	+0.8%	+$2.53K	0.09%	41
2022 Q2	$360K	Sell	6,867 -363	-5%	-$18.5K	0.1%	39
2022 Q1	$374K	Buy	7,230 +252	+4%	+$13.1K	0.09%	41
2021 Q4	$412K	Buy	6,978 +196	+3%	+$9.71K	0.09%	41
2021 Q3	$292K	Buy	6,782 +50	+0.7%	+$2.21K	0.07%	56
2021 Q2	$264K	Buy	6,732 +75	+1%	+$2.92K	0.06%	67
2021 Q1	$241K	Buy	6,657 +238	+4%	+$8.45K	0.06%	73
2020 Q4	$236K	Sell	6,419 -1,059	-14%	-$38.8K	0.06%	71
2020 Q3	$258K	Sell	7,478 -62	-0.8%	-$2.17K	0.08%	59
2020 Q2	$247K	Buy	7,540 +160	+2%	+$5.44K	0.08%	51
2020 Q1	$228K	Sell	7,380 -1,160	-14%	-$39.5K	0.07%	48
2019 Q4	$317K	Hold	8,540	–	–	0.09%	64
2019 Q3	$291K	Sell	8,540 -559	-6%	-$20.3K	0.1%	63
2019 Q2	$374K	Sell	9,099 -581	-6%	-$23.1K	0.14%	55
2019 Q1	$390K	Buy	9,680 +585	+6%	+$23.4K	0.17%	51
2018 Q4	$377K	Buy	+9,095	New	+$378K	0.22%	54

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TimeScale Financial's PFE Position: Q2 2023 in Review

TimeScale Financial increased its Pfizer (PFE) stake by 0.65% in Q2 2023, buying an estimated $973 and bringing the position to 3,882 shares worth $142K. The position accounts for 0.03% of the portfolio, ranked #124.

TimeScale Financial first reported a position in PFE in Q4 2018 and has held it in 19 quarters since. The position peaked at $412K in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

TimeScale Financial held 3,882 shares of Pfizer worth $142K as of Q2 2023.
TimeScale Financial bought 25 Pfizer shares in Q2 2023, an estimated $973.
Pfizer made up 0.03% of TimeScale Financial's portfolio in Q2 2023, its #124 holding.
TimeScale Financial first reported a position in Pfizer in Q4 2018 and has held it in 19 quarters since.
TimeScale Financial's Pfizer position peaked at $412K in Q4 2021.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.